These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24716965)

  • 41. The impact of subdividing the "atypical" category for urinary cytology on patient management.
    Glass R; Cocker R; Rosen L; Coutsouvelis C; Chau K; Slim F; Brenkert R; Sheikh-Fayyaz S; Farmer P; Das K
    Diagn Cytopathol; 2016 Jun; 44(6):477-82. PubMed ID: 26991372
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suspicious urine cytology (class III) in patients with bladder cancer: should it be considered as negative or positive?
    Raitanen MP; Aine RA; Kaasinen ES; Liukkonen TJ; Kylmälä TM; Huhtala H; Tammela TL;
    Scand J Urol Nephrol; 2002; 36(3):213-7. PubMed ID: 12201938
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
    Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
    J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased risk of malignancy for non-atypical urothelial cell groups compared to negative cytology in voided urine. Morphological changes with LBC.
    Granados R; Butrón M; Santonja C; Rodríguez JM; Martín A; Duarte J; Camarmo E; Corrales T; Aramburu JA
    Diagn Cytopathol; 2016 Jul; 44(7):582-90. PubMed ID: 27089849
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Applying the Paris system for reporting urine cytology to challenging cytology cases.
    Glass R; Rosca O; Raab S; Szabelska J; Chau K; Sheikh-Fayyaz S; Cocker R
    Diagn Cytopathol; 2019 Jul; 47(7):675-681. PubMed ID: 31017746
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The value of the "suspicious for urothelial carcinoma" cytology category: a correlative study of 4 years including 337 patients.
    Ton Nu TN; Kassouf W; Ahmadi-Kaliji B; Charbonneau M; Auger M; Brimo F
    Cancer Cytopathol; 2014 Nov; 122(11):796-803. PubMed ID: 24909774
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Application of The Paris System to atypical urine cytology samples: correlation with histology and UroVysion
    Miki Y; Neat M; Chandra A
    Cytopathology; 2017 Apr; 28(2):88-95. PubMed ID: 27601215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Should the BK polyomavirus cytopathic effect be best classified as atypical or benign in urine cytology specimens?
    Allison DB; Olson MT; Lilo M; Zhang ML; Rosenthal DL; VandenBussche CJ
    Cancer Cytopathol; 2016 Jun; 124(6):436-42. PubMed ID: 26929126
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison between cytospin and liquid-based cytology in urine specimens classified according to the Paris System for Reporting Urinary Cytology.
    Straccia P; Bizzarro T; Fadda G; Pierconti F
    Cancer Cytopathol; 2016 Jul; 124(7):519-23. PubMed ID: 26989867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.
    Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA
    Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of atypical urine cytology in a tertiary care center.
    Deshpande V; McKee GT
    Cancer; 2005 Dec; 105(6):468-75. PubMed ID: 16080177
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Value of CK20 immunocytochemistry as an adjuvant to urine liquid-based cytology in detection of urothelial carcinoma].
    Li M; Li HX; Guo HQ; Zhao H; Zhao LL; Ma JH; Li CL; Cao J; Pan QJ
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):669-73. PubMed ID: 23159079
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of Urinary Cytology for Detecting Recurrence in Remnant Urothelium After Radical Cystectomy: Insights From a 10-year Cytology Database.
    Pichler R; Tulchiner G; Oberaigner W; Schaefer G; Horninger W; Brunner A; Heidegger I
    Clin Genitourin Cancer; 2017 Oct; 15(5):e783-e791. PubMed ID: 28434947
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An institutional experience evaluating hTERT immunostaining in 100 consecutive ThinPrep urine specimens.
    Xing J; Han M; Monaco SE; Dhir R; Roy S; Pantanowitz L
    J Am Soc Cytopathol; 2021; 10(1):88-93. PubMed ID: 32354607
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The application of the Johns Hopkins Hospital Template on urine cytology.
    Wu HH; Redelman M; Chen S; Grignon DJ; Cramer HM
    Diagn Cytopathol; 2015 Aug; 43(8):593-7. PubMed ID: 25721938
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification.
    Whisnant RE; Bastacky SI; Ohori NP
    Diagn Cytopathol; 2003 Apr; 28(4):186-90. PubMed ID: 12672093
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-grade urothelial carcinoma in urine cytology with jet black and smooth or glassy chromatin.
    Renshaw AA; Gould EW
    Cancer Cytopathol; 2018 Jan; 126(1):64-68. PubMed ID: 29072816
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of chromosomal aberrations in patients with benign conditions and reactive changes in urinary cytology.
    Tapia C; Glatz K; Obermann EC; Grilli B; Barascud A; Herzog M; Schönegg R; Savic S; Bubendorf L
    Cancer Cytopathol; 2011 Dec; 119(6):404-10. PubMed ID: 21732550
    [TBL] [Abstract][Full Text] [Related]  

  • 59. One year of experience using the Paris System for Reporting Urinary Cytology.
    Meilleroux J; Daniel G; Aziza J; d'Aure DM; Quintyn-Ranty ML; Basset CM; Evrard SM; Courtade-Saidi MM
    Cancer Cytopathol; 2018 Jun; 126(6):430-436. PubMed ID: 29663682
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High diagnostic efficacy of 5-aminolevulinic acid-induced fluorescent urine cytology for urothelial carcinoma.
    Yamamichi G; Nakata W; Tani M; Tsujimura G; Tsujimoto Y; Nin M; Mimura A; Miwa H; Tsujihata M
    Int J Clin Oncol; 2019 Sep; 24(9):1075-1080. PubMed ID: 30976938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.